HR 3288 · in committee · significant
Access to Prescription Digital Therapeutics Act of 2025
- healthcare
What this bill does
- Medicare and Medicaid will cover prescription digital therapeutics, which are software apps that prevent, manage, or treat medical conditions.
- Manufacturers of these digital therapeutics and patients who use them through Medicare or Medicaid are affected.
- CMS will establish a payment methodology for manufacturers; manufacturers must report data on private payor coverage or face penalties.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
What evidence exists that prescription digital therapeutics are effective enough to warrant Medicare and Medicaid coverage alongside traditional treatments?
- 02
How might requiring manufacturers to report private payor coverage data affect their willingness to develop digital therapeutics for less profitable conditions?
- 03
Who bears the cost if CMS payment rates for digital therapeutics are set lower than manufacturers need to sustain development and support?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-OK-1
Kevin Hern
Citizen cosponsors
0
In Congress
9/ 435
House Reps cosponsoring
Introduced 2025-05-08
Joining the bill
Legislative timeline
2025-05-08 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-08 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-08 · IntroReferral
Introduced in House
2025-05-08 · IntroReferral
Introduced in House

Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.